Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Overview01:00

Drug Toxicity: Overview

117
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
117
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

100
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
100
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

223
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
223
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.7K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

93
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
93
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

106
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
106

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CMA-Nano: A DNA Methylation Detection Method for Nanopore Sequencing Data Based on a Cross-Modal Attention Mechanism.

ACS omega·2026
Same author

An Explainable Deep Learning Framework Integrating DNA Sequence and Transcription Initiation Signals for Gene Expression Prediction.

ACS synthetic biology·2026
Same author

LysePred: A Multiscale Convolutional Neural Network for Predicting Hemolytic Activity of Antimicrobial Peptides.

ACS synthetic biology·2026
Same author

An Interpretable Deep Learning Framework Leveraging RNA Foundation Model and Capsule Networks for Accurate Prediction of RNA 2'-O-Methylation Sites.

Journal of chemical information and modeling·2026
Same author

MPMFMol: Multitask Self-Supervised Pretraining with Multimodal Fine-Tuning for Molecular Property Prediction.

Journal of chemical information and modeling·2026
Same author

Quantum computing applications in drug discovery.

Briefings in bioinformatics·2026

Related Experiment Video

Updated: Mar 14, 2026

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.8K

FGMA: A Functional Group-enhanced Deep Learning Method for Drug Toxicity Prediction.

Yue Cheng1, Jianbo Qiao2, Siqi Chen2

  • 1School of Electronic and Communication Engineering, Shenzhen Polytechnic University, Shenzhen, 518055, China.

Current Drug Targets
|March 12, 2026
PubMed
Summary
This summary is machine-generated.

A new framework, FGMA, enhances drug toxicity prediction by combining functional groups and molecular fingerprints. This approach improves efficiency and interpretability, aiding in the design of safer drug candidates.

Keywords:
Deep learningFunctional groupGNNMolecular representationdrug toxicity predictionmolecular fingerprint.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K

Related Experiment Videos

Last Updated: Mar 14, 2026

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Toxicology

Background:

  • Accurate drug toxicity prediction is crucial for efficient drug discovery.
  • Existing atom-based methods face computational challenges with complex molecules.
  • There is a need for more efficient and powerful predictive models.

Purpose of the Study:

  • Introduce FGMA, a novel framework for efficient drug toxicity prediction.
  • Address the computational inefficiency of current methods.
  • Enhance the accuracy and interpretability of toxicity assessments.

Main Methods:

  • FGMA integrates functional groups with molecular fingerprints for multi-view encoding.
  • Key functional groups are extracted as unified entities to reduce computational load.
  • A cross-attention mechanism combines functional groups with MACCS fingerprints for comprehensive molecular representation.

Main Results:

  • FGMA demonstrates high accuracy and robustness in toxicity prediction tasks.
  • Interpretability analyses successfully identified specific structural features and functional groups linked to toxicity.
  • The framework effectively balances computational efficiency with representational power.

Conclusions:

  • Combining functional groups and fingerprints is an effective strategy for toxicity prediction.
  • FGMA provides valuable insights into structure-toxicity relationships for safer drug design.
  • FGMA accelerates drug discovery through faster, more insightful safety assessments.